Fuan Pharmaceutical(Group) Co.,Ltd.’s Net Profit Rose 90.5% in First Three Quarters of 2023

Fuan Pharmaceutical(Group) Co.,Ltd. (福安药业(集团)股份有限公司) (300194.SZ) reported a net profit of 254.8 million yuan in the first three quarters of 2023, up 90.5% year-on-year.

Meanwhile, the company posted 2 billion yuan in revenue, up 11.2% year-on-year.

At the end of the reporting period, it had 6.2 billion yuan in total assets and 2 billion yuan in total liabilities, with a liability-to-asset ratio of 32.6%.